Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Replimune Group | REPL | Nov 27, 2024 | 14.05 | -2.29 |
ReposiTrak | TRAK | Nov 27, 2024 | 22.85 | -1.51 |
Republic Bancorp A | RBCAA | Nov 27, 2024 | 77.36 | +0.38 |
Republic Services | RSG | Nov 27, 2024 | 218.28 | -0.21 |
Research Frontiers | REFR | Nov 27, 2024 | 1.95 | +0.52 |
Research Solutions | RSSS | Nov 27, 2024 | 3.42 | -1.44 |
Reservoir Media | RSVR | Nov 27, 2024 | 9.27 | -0.22 |
ReShape Lifesciences | RSLS | Nov 27, 2024 | 5.75 | +1.23 |
Resideo Technologies | REZI | Nov 27, 2024 | 27.14 | -0.66 |
ResMed | RMD | Nov 27, 2024 | 249.33 | -0.26 |
Resources Connection | RGP | Nov 27, 2024 | 8.44 | 0.00 |
Restaurant Brands International | QSR | Nov 27, 2024 | 70.18 | +1.40 |
Retail Bull 3X Direxion | RETL | Nov 27, 2024 | 11.13 | +0.36 |
Retail ETF Market Vectors | RTH | Nov 27, 2024 | 230.69 | +0.30 |
Retail Opportunity Investments | ROIC | Nov 27, 2024 | 17.39 | -0.11 |
ReTo Eco-Solutions | RETO | Nov 27, 2024 | 1.00 | +1.01 |
Retractable Technologies | RVP | Nov 27, 2024 | 0.61 | +0.16 |
REV Group | REVG | Nov 27, 2024 | 30.85 | 0.00 |
Revance Therapeutics | RVNC | Nov 27, 2024 | 3.78 | -5.97 |
Revelation Biosciences | REVB | Nov 27, 2024 | 0.76 | +0.99 |
Revenueshares Largecap | RWL | Nov 27, 2024 | 103.90 | -0.02 |
Revenueshares Midcap | RWK | Nov 27, 2024 | 125.27 | -0.35 |
Revenueshares Smallcap | RWJ | Nov 27, 2024 | 48.92 | +0.16 |
Revenueshares Ultra Dividend Fund | RDIV | Nov 27, 2024 | 52.66 | +0.11 |
Reviva Pharmaceuticals | RVPH | Nov 27, 2024 | 1.14 | +1.79 |
Revolution Medicines | RVMD | Nov 27, 2024 | 58.58 | -0.09 |
Revolve Group A | RVLV | Nov 27, 2024 | 36.93 | -4.82 |
Revvity | RVTY | Nov 27, 2024 | 116.23 | +1.01 |
REX American Resources | REX | Nov 27, 2024 | 43.25 | +0.70 |
Rexford Industrial Realty | REXR | Nov 27, 2024 | 42.55 | +0.47 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.